Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

Background No head-to-head clinical trials have been published comparing guanfacine extended release (GXR) and atomoxetine (ATX): two nonstimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). However, other study designs or methods could be used to indirectly compa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2013-11, Vol.27 (11), p.943-953
Hauptverfasser:	Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Atomoxetine Hydrochloride Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - psychology Attention deficit hyperactivity disorder Child Comparative Effectiveness Research Delayed-Action Preparations Dose-Response Relationship, Drug Drug therapy Guanfacine - administration & dosage Guanfacine - therapeutic use Humans Hyperactivity Medicine Medicine & Public Health Neurology Neurosciences Original Original Research Article Pharmacotherapy Propylamines - administration & dosage Propylamines - therapeutic use Psychiatric Status Rating Scales Psychiatry Psychopharmacology Randomized Controlled Trials as Topic - statistics & numerical data Severity of Illness Index Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!